@article{6b97ff64ed9e489ba5f456534233a049,
title = "Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism",
abstract = "Patients with venous thromboembolism (VTE) are prone to the development of both short-term and long-term complications that can substantially affect their functional capacity and quality of life. Patients with deep vein thrombosis (DVT) often develop recurrent VTE or the post-thrombotic syndrome, whereas patients with pulmonary embolism (PE) can develop long-term symptoms and functional limitations along a broad spectrum extending to full-blown chronic thromboembolic pulmonary hypertension. Clinicians who care for patients showing severe clinical manifestations of DVT and PE are often faced with challenging decisions concerning whether and how to escalate to more aggressive treatments such as those involving the use of thrombolytic drugs. The purpose of this chapter is to provide guidance on how best to individualize care to these patients.",
keywords = "Anticoagulants, Direct oral anticoagulants (DOAC), New oral anticoagulants (NOAC), Pulmonary embolism, Thrombolytic therapy, Venous thromboembolism",
author = "Suresh Vedantham and Gregory Piazza and Sista, {Akhilesh K.} and Goldenberg, {Neil A.}",
note = "Funding Information: SVedantham: Research support from Covidien, Bayer Healthcare, BSN Medical, Genentech, Cook Inc., Volcano, Inc. G Piazza: Research support from BMS, Daiichi-Sankyo, BTG/EKOS, and Janssen A Sista and N A Goldenberg: None. Funding Information: We wish to acknowledge the support provided by Myelin and Associates with the preparation of this manuscript for submission. The work contained in this manuscript was partially funded by support from the following companies: Boehringer Ingelheim, Daiichi Sankyo and Janssen Pharmaceuticals. This guidance document is endorsed by the Anticoagulation Forum{\textquoteright}s Board of Directors: Mark Crowther, MD, MSc, FRCPC, Jack E. Ansell, MD, Allison Burnett, PharmD, Nathan Clark, PharmD, Adam Cuker, MD, David Garcia, MD, Scott Kaatz, DO, MSc, FACP, Renato D. Lopes, MD, PhD, Tracy Minichiello, MD, Edith Nutescu, PharmD, FCCP, Lynn Oertel, MS, ANP, CACP, Eva Kline-Rogers, MS, RN, NP,Terri Schnurr, RN, CCRC, Michael Streiff, MD, Diane Wirth, ANP, CACP, BCPS, CACP, Daniel Witt, Pharm D, Ann Wittkowsky, PharmD, CACP, FASHP, FCCP. Publisher Copyright: {\textcopyright} 2016, The Author(s).",
year = "2016",
month = jan,
day = "1",
doi = "10.1007/s11239-015-1318-z",
language = "English (US)",
volume = "41",
pages = "68--80",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "1",
}